栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/26 | 1,878 | 1,895 | 1,850 | 1,856 | -7 | -0.4% | 107,500 |
| 2024/02/22 | 1,868 | 1,869 | 1,838 | 1,863 | -14 | -0.7% | 130,800 |
| 2024/02/21 | 1,889 | 1,902 | 1,860 | 1,877 | +3 | +0.2% | 98,700 |
| 2024/02/20 | 1,896 | 1,898 | 1,873 | 1,874 | -22 | -1.2% | 142,400 |
| 2024/02/19 | 1,911 | 1,918 | 1,883 | 1,896 | -15 | -0.8% | 88,700 |
| 2024/02/16 | 1,935 | 1,935 | 1,906 | 1,911 | +3 | +0.2% | 133,300 |
| 2024/02/15 | 1,959 | 1,964 | 1,902 | 1,908 | -32 | -1.6% | 140,400 |
| 2024/02/14 | 1,950 | 1,964 | 1,931 | 1,940 | -10 | -0.5% | 125,400 |
| 2024/02/13 | 1,943 | 1,962 | 1,926 | 1,950 | +7 | +0.4% | 151,200 |
| 2024/02/09 | 1,939 | 1,962 | 1,938 | 1,943 | +4 | +0.2% | 143,100 |
| 2024/02/08 | 1,930 | 1,957 | 1,915 | 1,939 | ±0 | ±0% | 123,900 |
| 2024/02/07 | 1,950 | 1,960 | 1,922 | 1,939 | -6 | -0.3% | 175,900 |
| 2024/02/06 | 1,947 | 1,959 | 1,907 | 1,945 | -6 | -0.3% | 295,600 |
| 2024/02/05 | 1,966 | 1,966 | 1,929 | 1,951 | -24 | -1.2% | 216,500 |
| 2024/02/02 | 1,942 | 1,987 | 1,933 | 1,975 | +32 | +1.6% | 279,900 |
| 2024/02/01 | 1,835 | 1,963 | 1,824 | 1,943 | +100 | +5.4% | 515,200 |
| 2024/01/31 | 1,850 | 1,914 | 1,828 | 1,843 | +104 | +6% | 450,900 |
| 2024/01/30 | 1,781 | 1,792 | 1,729 | 1,739 | -39 | -2.2% | 124,300 |
| 2024/01/29 | 1,768 | 1,784 | 1,765 | 1,778 | +10 | +0.6% | 113,000 |
| 2024/01/26 | 1,760 | 1,788 | 1,757 | 1,768 | +13 | +0.7% | 146,300 |
| 2024/01/25 | 1,741 | 1,757 | 1,736 | 1,755 | +18 | +1% | 117,300 |
| 2024/01/24 | 1,740 | 1,747 | 1,731 | 1,737 | -23 | -1.3% | 89,900 |
| 2024/01/23 | 1,770 | 1,787 | 1,756 | 1,760 | -13 | -0.7% | 98,400 |
| 2024/01/22 | 1,758 | 1,779 | 1,758 | 1,773 | +15 | +0.9% | 78,000 |
| 2024/01/19 | 1,760 | 1,769 | 1,736 | 1,758 | +6 | +0.3% | 139,800 |
| 2024/01/18 | 1,734 | 1,759 | 1,729 | 1,752 | +15 | +0.9% | 93,200 |
| 2024/01/17 | 1,820 | 1,838 | 1,735 | 1,737 | -80 | -4.4% | 289,100 |
| 2024/01/16 | 1,835 | 1,849 | 1,813 | 1,817 | -3 | -0.2% | 280,300 |
| 2024/01/15 | 1,802 | 1,823 | 1,790 | 1,820 | +32 | +1.8% | 183,300 |
| 2024/01/12 | 1,738 | 1,798 | 1,715 | 1,788 | +59 | +3.4% | 270,800 |
| 2024/01/11 | 1,735 | 1,742 | 1,706 | 1,729 | +4 | +0.2% | 103,500 |
| 2024/01/10 | 1,705 | 1,741 | 1,700 | 1,725 | +25 | +1.5% | 145,000 |
| 2024/01/09 | 1,704 | 1,720 | 1,699 | 1,700 | -10 | -0.6% | 123,400 |
| 2024/01/05 | 1,713 | 1,720 | 1,694 | 1,710 | +3 | +0.2% | 148,700 |
| 2024/01/04 | 1,701 | 1,709 | 1,678 | 1,707 | -2 | -0.1% | 69,700 |
| 2023/12/29 | 1,718 | 1,726 | 1,697 | 1,709 | -9 | -0.5% | 103,300 |
| 2023/12/28 | 1,696 | 1,718 | 1,693 | 1,718 | +11 | +0.6% | 198,300 |
| 2023/12/27 | 1,700 | 1,709 | 1,695 | 1,707 | +4 | +0.2% | 80,900 |
| 2023/12/26 | 1,700 | 1,707 | 1,691 | 1,703 | +5 | +0.3% | 97,400 |
| 2023/12/25 | 1,722 | 1,723 | 1,692 | 1,698 | -21 | -1.2% | 67,900 |
| 2023/12/22 | 1,701 | 1,721 | 1,701 | 1,719 | +8 | +0.5% | 72,500 |
| 2023/12/21 | 1,706 | 1,718 | 1,701 | 1,711 | -2 | -0.1% | 82,300 |
| 2023/12/20 | 1,718 | 1,728 | 1,705 | 1,713 | +2 | +0.1% | 95,900 |
| 2023/12/19 | 1,707 | 1,718 | 1,693 | 1,711 | -2 | -0.1% | 127,700 |
| 2023/12/18 | 1,689 | 1,722 | 1,681 | 1,713 | +8 | +0.5% | 108,200 |
| 2023/12/15 | 1,734 | 1,735 | 1,698 | 1,705 | -22 | -1.3% | 160,300 |
| 2023/12/14 | 1,729 | 1,736 | 1,703 | 1,727 | -1 | -0.1% | 137,700 |
| 2023/12/13 | 1,724 | 1,740 | 1,707 | 1,728 | +21 | +1.2% | 168,200 |
| 2023/12/12 | 1,730 | 1,733 | 1,691 | 1,707 | -18 | -1% | 169,600 |
| 2023/12/11 | 1,748 | 1,748 | 1,714 | 1,725 | -3 | -0.2% | 135,500 |
51～
100
件表示中 / 6706件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 204,100円 | +7.6% | +57.5% | 2.60% | 15.76倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| ゼリア新薬 | 200,100円 | +9.6% | +17.5% | 2.30% | 11.31倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ＪＣＲファーマ | 79,800円 | +32.2% | +84.6% | 2.51% | 13.64倍 | 1.78倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 208,300円 | +2.6% | +5.1% | 1.92% | 9.52倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 生化学 | 73,800円 | +7.9% | -26.7% | 3.52% | 15.49倍 | 0.56倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
市場注目の銘柄
チャート関連のコラム
